Analyst Picks Dr Reddy's, M&M, and Tata Consumer as Top Indian Stocks to Buy Monday

The Quick Take

• Analyst Sumeet Bagadia of Choice Broking recommends buying Dr Reddy's Labs, Mahindra & Mahindra, and Tata Consumer Products for Monday June 29
• The three picks span pharma, auto, and FMCG sectors, reflecting a diversified defensive-growth tilt amid mixed market signals
• Indian markets have remained broadly strong with easing crude oil prices providing a macro tailwind for domestic consumption

Analyst Sumeet Bagadia of Choice Broking has identified Dr Reddy's Laboratories, Mahindra & Mahindra, and Tata Consumer Products as his top three stock picks for Monday June 29 on the Indian equity market. This selection spans three of India's most structurally resilient sectors: pharmaceuticals, automotive, and fast-moving consumer goods. The diversified sectoral allocation suggests a strategy balancing defensive earnings visibility in pharma (Dr Reddy's) with a cyclical growth bet in the EV and farm equipment transition (M&M) and a domestic consumption play benefiting from easing input cost pressures (Tata Consumer).

Dr Reddy's Laboratories has been a consistent performer in the Indian pharma space, with strong US generic filings and a growing biosimilar pipeline that positions it well in high-value therapeutic segments. Mahindra & Mahindra continues to benefit from its dominant position in the UV and SUV segment of the Indian auto market, while its tractors and EV Scorpio-N have received strong consumer reception. Tata Consumer Products — a Tata Group company — benefits from easing commodity prices reducing pressure on tea, salt, and packaged food margins, with improving rural and urban consumption. Together these three companies represent a cross-section of India's mid-to-large cap quality universe.

The Indian equity market watchpoints for the coming week include Bank Nifty performance around the 57,000-59,000 range, crude oil price movements (easing oil is a direct positive for input-cost-sensitive consumer and pharma businesses), and any Reserve Bank of India communication ahead of the next policy meeting. The macro variable for all three stock picks is domestic inflation—if CPI remains benign, the RBI has room to maintain supportive monetary conditions, sustaining the earnings environment for quality mid-large cap businesses in the pharma, auto, and FMCG sectors.

Synthesized from 1 source.